News and Events
Will blue packets replace pink ones soon? After decades of research, development of a male birth control may now be one step closer.
A paper authored by Drs. Gunda Georg, Jon Hawkinson, Kwon Ho Hong, and Shameem Sultana Syeda, all from the Institute for Therapeutics Discovery and Development, was publicized in the most recent press release of the American Chemical Society. The paper explores the potential of the plant extract ouabain as a male contraceptive agent. Ouabain has long been used by African hunters as the lethal agent for poison-tipped arrows, but in small doses it has also shown efficacy in lowering fertility rates in males.
Gunda Georg is featured in several stories for her research to develop a birth control pill for men that has its origin in an arrow poison.
Gunda Georg is the PI of a $8.3M NIH U54 Center Grant for the project, "Contraceptive Discovery, Development, and Behavioral Research Center (2017-2021)." Other College of Pharmacy researchers involved are Leigh Allen, Jon Hawkinson, Michael Walters and Henry Wong. The center also involves an additional five interdisciplinary groups that are involved in the discovery and development of non-hormonal male contraceptive agents and the investigation of contraceptive use.
Using precision medicine study individual resistance to ER+ breast cancer inhibitors
Researchers: Michael Walters, University of Minnesota; Dr. Liewei Wang, Mayo Clinic
Natalia Tretyakova received a $342,947 NIH grant for her project, "DNA Cross-Linking By Diepoxybutane."